Cargando…
Circulating Levels of Ang/Tie2 and VEGF-a Pathway Mediators Are Associated with Clinical Severity, Endothelial Barrier Disruption and Coagulation Activation in COVID-19
Background: the pathogenesis of severe COVID-19 involves the deregulated activation of different compartments of immunothrombosis, which are otherwise important for pathogen eradication and tissue repair. Coagulation activation, angiogenesis and alterations of endothelial barrier (EB) are elements o...
Autores principales: | de Moraes, Carla Roberta Peachazepi, de Borba Junior, Ivanio Teixeira, de Lima, Franciele, Barbosa, Mayck Silva, Huber, Stephany Cares, Palma, Andre C., Nunes, Thyago A., Ulaf, Raisa G., Ribeiro, Luciana C., Bernandes, Ana Flavia, Bombassaro, Bruna, Dertkigil, Sergio S., Moretti, Maria Luiza, Bizzacchi, Joyce Annichino, Mansour, Eli, Velloso, Lício Augusto, Maranhão Costa, Fábio Trindade, Orsi, Fernanda Andrade, De Paula, Erich V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701641/ http://dx.doi.org/10.1182/blood-2021-152771 |
Ejemplares similares
-
Sars-Cov-2 Infection Promotes Endothelial Dysfunction and Thrombosis in a Mouse Model of COVID-19
por: Aiolfi, Roberto, et al.
Publicado: (2021) -
Sars-Cov-2 Induced Endotheliopathy and the Impact on Clinical Outcomes in Critically Ill Pediatric Patients
por: Agarwal, Shreya, et al.
Publicado: (2021) -
Inhibition of Sars-Cov-2 Viral Replication and In Vivo Thrombus Formation By a Novel Plant Flavonoid
por: Yang, Moua, et al.
Publicado: (2021) -
The Deglycosylated Form of 1E12, a Monoclonal Anti-PF4 IgG, Strongly Inhibits Antibody-Triggered Cellular Activation in Vaccine-Induced Thrombotic Thrombocytopenia, and Is a Potential New Treatment for Vιττ
por: Vayne, Caroline, et al.
Publicado: (2021) -
The Role of PF4 Antibodies in Pediatric Sars-Cov-2 Infections
por: Chiem, Meady, et al.
Publicado: (2021)